Axim Biotechnologies Inc (AXIM)

Not featured in screeners

Not featured in screeners

Ticker: AXIM Exchange: OTC

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for Axim Biotechnologies Inc

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Download results Settings

Proposed sale 15 Sep 2022

Value US$3,135,713.46 | Price 197.53 | Shares 46,818

Buy 24 Aug 2022

Value US$2,194,041.92 | Price 25.33 | Shares 55,945 (-37.9%)

Buy 19 Mar 2020

Value US$0.00 | Price 0.00 | Shares 6,000,000

Sale 21 Mar 2014

Value US$400,000,000.00 | Price 400.00 | Shares 1,000,000 (-100.0%)

Sale 21 Mar 2014

Value US$160,000,000,000.00 | Price 8,000.00 | Shares 20,000,000 (-100.0%)

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2022-10-07	2022-09-15	PrS Proposed sale	WILSON-DAVIS & CO., INC. Director Non-Executive Director	46,818 197.53 US$3,135,713	46,818	197.53	US$3,135,713
2022-08-31	2022-08-24	B Purchase	Valencia Catalina Large shareholder	55,945 -37.9% 25.33 US$2,194,042	55,945 -37.9%	25.33	US$2,194,042
2022-09-23	2020-03-19	B Purchase	HUEMOELLER JOHN WALTER II Chief Executive Officer Executive Director	63,448 86.89 US$3,611,276	63,448	86.89	US$3,611,276
2014-04-30	2014-03-21	S Sale	SAMUELS ROSEMARY PRESIDENT, CEO, CFO Executive Director Large shareholder	1,000,000 -100.0% 400.00 US$400,000,000	1,000,000 -100.0%	400.00	US$400,000,000
2014-04-30	2014-03-21	S Sale	SAMUELS ROSEMARY PRESIDENT, CEO, CFO Executive Director Large shareholder	20,000,000 -100.0% 8,000.00 US$160,000,000,000	20,000,000 -100.0%	8,000.00	US$160,000,000,000

More insider trading research around Axim Biotechnologies Inc